Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Finger and Thumb Splints Can Help Treat Trigger Finger

Stenosing tenosynovitis, better known as “trigger finger,” is a condition where one or more fingers lock or catch when a person bends or straightens a finger. The digit typically flexes with a sudden snap, like a trigger being pulled and released. Trigger finger may be treated with rest, splints, NSAIDs, or steroid injections. What is…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Stenosing tenosynovitis, better known as “trigger finger,” is a condition where one or more fingers lock or catch when a person bends or straightens a finger. The digit typically flexes with a sudden snap, like a trigger being pulled and released. Trigger finger may be treated with rest, splints, NSAIDs, or steroid injections.

What is Trigger Finger?

Trigger finger can occur in any finger, but the ring finger and thumb are most commonly affected1. When the condition occurs in the thumb, it is usually called “trigger thumb.” Long cord-like flexor tendons attach the muscles of the forearm to the bones of the fingers. Normally, the flexor tendons glide smoothly through a tunnel in the palm known as the “tendon sheath,” allowing fingers to bend as muscles contract. The tendons are assisted by pulleys that hold them close to the finger bones. These pulleys may become inflamed and thicken, making it difficult for the tendon to glide smoothly. Over time, the flexor then develops a small nodule on its surface that catches or pops when it passes through the pulley. In severe cases, the finger may lock in place and become stuck in a bent position.

What Causes Trigger Finger?

Doctors have not pinpointed the root cause of trigger finger, but it is more common in women, as well as those with diabetes, gout, and rheumatoid arthritis, and it may appear after forceful use of the hand2. Occupations and hobbies that involve repeated and strong gripping may also lead to the condition. Finally, trigger finger may arise as a complication of carpal tunnel syndrome surgery, especially in the first six months after the procedure3.

Symptoms of Trigger Finger

In the early stages of trigger finger, a person may experience discomfort or sensitivity to pressure at the base of the finger or thumb, and may also feel a lump. As the condition progresses, the patient experiences finger stiffness, especially in the morning or when gripping an object, and may find themselves using the other hand to straighten the finger. It is common to experience a popping or clicking sensation as the finger or thumb is flexed. The digit will increasingly catch or lock in a bent position, and in extreme cases may prove unable to be straightened.

Treating Trigger Finger

The first step in treating mild cases of trigger finger is to rest the hand and avoid activities that make the condition worse. Gentle stretching exercises can also help decrease stiffness and improve range of motion in the finger. Over-the-counter medications, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), can help relieve pain and inflammation. In more severe cases, a doctor may treat the condition with steroid injections to the tendon sheath at the base of the trigger finger. As a last resort, surgery may also be considered to prevent permanent stiffness4.

Wearing a splint for daytime support or while sleeping at night will help keep the affected finger or thumb in a straight position. This may provide relief and help reduce inflammation. AliMed offers a number of products to help treat trigger finger:

  • Trigger Finger Solution(TFS)TFS helps reduce pressure and can be worn on any finger with complete freedom of movement. Frequent grasping or contact with a particular object can cause fat pad atrophy at base of finger. TFS helps reduce pressure in this area, allowing daily activities to resume while fat pad heals. Repetitive contact with padded sleeve also helps identify activity causing the problem, so an alternative method can be adopted. Can be worn on any finger with complete freedom of movement. Blended neoprene rubber and nylon fabric.
  • Oval-8® Finger SplintsOval-8 Finger Splints align and stabilize the PIP and DIP joints. Treat up to six different injuries with a simple turn of the splint. Ideal for tendon or ligament injuries, protecting healing fractures, controlling unstable joints, and preventing or managing finger contractures. One splint can treat swan-neck or boutonniere deformity, mallet finger injury, trigger ginger or lateral instability depending on application. Two splints can be combined to immobilize the joint completely. Splints use broad bands to distribute pressure for wearing comfort. Seamless molded plastic provides durability. Open design eliminates skin issues and discomfort.

To find out more about finger and thumb splints and braces available from AliMed, click here.

REFERENCES

  1. https://orthoinfo.aaos.org/en/diseases–conditions/trigger-finger
  2. http://www.assh.org/handcare/hand-arm-conditions/trigger-finger
  3. https://www.mayoclinic.org/diseases-conditions/trigger-finger/symptoms-causes/syc-20365100
  4. https://orthoinfo.aaos.org/en/diseases–conditions/trigger-finger

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512